Prostatic intraepithelial neoplasia in genetically engineered mice - Wikidata - awgldk - TriplyDB

Prostatic intraepithelial neoplasia in genetically engineered mice

Prostatic intraepithelial neoplasia in genetically engineered mice

http://www.wikidata.org/entity/Q35747658

about

SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation Krüppel cripples prostate cancer: KLF6 progress and prospects Pten dose dictates cancer progression in the prostate High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.Mouse models of prostate cancer: picking the best model for the question.eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.Dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced prostate carcinogenesis in CYP1A-humanized mice β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma.Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells.Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis.Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation.Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.The effect Akt2 deletion on tumor development in Pten(+/-) mice.Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice.Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model.B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.Murine prostate cancer inhibition by dietary phytochemicals--curcumin and phenyethylisothiocyanate Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression.Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice

P2860

Q24297526-7229DB3D-6F1F-42C5-9D46-9C10B9FEA650 Q24684219-3B8A2E70-0243-4D8F-B23C-950F0DA44E07 Q24791909-F040B98E-42F3-4AB1-8AA5-97CA4FEE217E Q27308667-44AC734E-9B19-4A17-AF47-E1D31EECB6C3 Q27311359-1E57BA4C-B318-4811-AF8A-806E42DBF1E0 Q27347240-C891E885-C69E-467A-89EA-27A06C778FB9 Q28485913-894D1D73-FDCA-4677-A091-28DC2D7D7D7C Q28535017-76BD9B60-E0C0-481E-888C-EA21DCB6304A Q30410016-31FA8304-DB9E-4545-B5F9-053A8ACE47D4 Q33535955-479CD4F4-3CB8-4D02-811B-6F2DDE27CED7 Q33617181-F2E0FBDC-557E-40F1-AA62-3BFF2728D930 Q33653171-51403505-0D33-46F3-B853-2E6528628249 Q33687282-EE9A6C72-12B4-483E-A8C9-3E0EF65F3EBD Q33705275-24FEF8DF-8D3C-40F4-9DC5-17FA222478F9 Q33743993-8AB66F02-667B-4D0C-9F3A-6B0D68E1C67C Q33940867-6BAD6754-4839-49E1-946A-6C6942699AA7 Q34069836-CC0F260F-10DB-466A-8961-26AD64D0C774 Q34093594-4A5B6670-9698-46FE-BC52-865DB242E886 Q34101297-E2841F03-A74C-4C16-9120-FCD8D2CC0F3A Q34539930-2F930589-6B54-4F51-92CD-9E0DDBEDC73B Q34558936-746FC65A-9E99-4027-8CDD-EB22155A02CD Q34693888-16A20BD5-0DBB-42E8-8C2C-6C2B1D56C6A0 Q34722551-DAA6CEDC-6FA8-408B-B4F5-1B816A87A8B1 Q34766615-8F5B72F2-6B60-4D60-9E8D-A31B20A27F33 Q34786771-2797F122-C425-40EE-B0E2-1D734BFE87F1 Q35060317-22FCF961-86C5-4C45-84F7-C4238FD3DBE9 Q35098014-2808D109-D331-492E-B41B-5B46EF015084 Q35140092-FD50A222-A953-4824-A756-800A8AE50AEC Q35153370-86CAC9F3-D4C6-4AA7-88E9-61F21D1BA2AF Q35554127-B20C3205-378C-4354-AE85-74D797877637 Q35738371-8FC81F61-6B77-4A86-BBC6-2578D76B73C0 Q36105484-A15C41DF-819B-448B-A29F-71AD3816BE77 Q36204972-656C298E-BB9C-493C-AAFD-789833B5E376 Q36243554-EF7D0C33-08C6-4AC4-B50E-884A8592933B Q36297949-65B9D0B5-0D58-4B28-A746-6368E85B7FFC Q36301754-BCE149D0-3F1B-4F73-8D88-D83B4E40C3D4 Q36357373-E9477DFE-31F0-4904-945A-B4957CDBB67E Q36359259-E2F682B2-6CE7-4B91-9E99-D6C146357C12 Q36386464-2D6A0B92-0F82-43E2-A110-F70CCA3E7CC3 Q36425851-7D777225-8491-4A1F-B209-275BB7D83D16

P2860

Prostatic intraepithelial neoplasia in genetically engineered mice

http://www.wikidata.org/entity/Q35747658

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Prostatic intraepithelial neoplasia in genetically engineered mice

@ast

Prostatic intraepithelial neoplasia in genetically engineered mice

@en

type

label

Prostatic intraepithelial neoplasia in genetically engineered mice

@ast

Prostatic intraepithelial neoplasia in genetically engineered mice

@en

prefLabel

Prostatic intraepithelial neoplasia in genetically engineered mice

@ast

Prostatic intraepithelial neoplasia in genetically engineered mice

@en

P1433

Q35747658-89FF63B6-1BBB-43E9-9546-0CA08720B9AB

P1476

Q35747658-68740900-ECBB-4CE6-A0DF-226F997606D0

P2093

Q35747658-3FDEE72C-5CE9-4FF8-95CC-A74188BC1081

Q35747658-5517CA58-05DE-456B-99BF-E20437E00C13

Q35747658-5C71753C-28D7-417C-BC9C-41DD640CF2CE

Q35747658-722A020D-EA05-4A5C-87A5-9A0756539F0B

Q35747658-8C0F03B5-8E9C-4192-9D74-944E5A2119A5

Q35747658-92C02D08-2641-4227-9802-661BA2383650

Q35747658-C455467F-9DE3-442A-A327-A6ADF6EB8373

P2860

Q35747658-073FF070-9D0D-417E-A6CD-BEEE308E5B17

Q35747658-07941E62-9758-47A1-8E01-24119B0510A1

Q35747658-13575EA3-294E-42D1-9977-7D70575947F6

Q35747658-19C76DE1-27C3-4283-83F4-BE14AD713156

Q35747658-1E6BA602-638F-44E8-9653-9D9446652EC0

Q35747658-54853AA3-8421-418D-BE29-6A367C2DE8CB

Q35747658-5919793A-90CF-44C5-8327-83EE23455452

Q35747658-5959C431-AAE3-48AE-9EBA-4B81B04DC41E

Q35747658-5B7BFF08-23CD-4BA0-A2E7-DE05EAA1DBB4

Q35747658-5CB0FFE6-3226-42FD-B100-444A6E52C3E6

P304

Q35747658-E7037FD0-5B19-4E7F-BF7A-4AD3F153A0C9

P31

Q35747658-81966A1A-999B-4E52-BBA8-CDBA8D91DAFD

P356

Q35747658-4EDE20D9-1372-4A11-8FAA-601DCB5DD259

P407

Q35747658-A8DB7282-20BC-4C7B-AF59-7DCEF7D84041

P433

Q35747658-B449BCBF-8CCA-4D24-8C9E-5C0FC2B94A6B

P478

Q35747658-50FDF528-693B-444D-970A-79F7B435A9CE

P577

Q35747658-C24C4196-CC3A-4297-85F0-C30D1FF7C573

P698

Q35747658-2D9376FA-8943-47F7-B584-43E462C2409E

P932

Q35747658-FCCE7A34-A150-44E0-880E-A3A4B62DE0FE

P356

S0002-9440(10)64228-9

P1433

The American Journal of Pathology

P1476

Prostatic intraepithelial neoplasia in genetically engineered mice

@en

P2093

Cory Abate-Shen

http://www.w3.org/2001/XMLSchema#string

Jae-Hak Park

http://www.w3.org/2001/XMLSchema#string

Jose J Galvez

http://www.w3.org/2001/XMLSchema#string

Judy E Walls

http://www.w3.org/2001/XMLSchema#string

Michael M Shen

http://www.w3.org/2001/XMLSchema#string

Minjung Kim

http://www.w3.org/2001/XMLSchema#string

Robert D Cardiff

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

Pten is essential for embryonic development and tumour suppression

Roles for Nkx3.1 in prostate development and cancer

A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.

A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

Mouse models of prostate cancer.

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease.

P304

727-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64228-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12163397

http://www.w3.org/2001/XMLSchema#string

P932

1850748

http://www.w3.org/2001/XMLSchema#string